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Abstract: Anthropometric indicators can predict the development of diabetes among adults. Among
them, a new indicator (Body Shape Index) was developed. Several cohort observational studies have
demonstrated that A Body Shape Index (ABSI) is a prominent indicator for mortality and morbidity.
Nevertheless, the predictive level of ABSI for diabetes varied among different ethnicities. This study
aimed to assess the predictive level of ABSI for diabetes compared to BMI in the Qatari population.
Date from 2536 Qatari adults aged 20–79 years attending the Qatar Biobank Study were used. Body
height, weight, and waist circumference were measured. Blood samples were measured for glucose.
The association between ABSI, BMI, and diabetes was assessed using a logistic regression. Both ABSI
and BMI were positively associated with diabetes after adjusting for potential confounding factors.
ABSI had a stronger association with diabetes than BMI. Per 1 SD increment of ABSI and BMI, the
z-score had an odds ratios of 1.85 (1.54–2.23) and 1.34 (1.18–1.51) for diabetes, respectively. ABSI and
BMI are significantly associated with diabetes in the Qatari population. ABSI is a better predictor for
the risk of diabetes than BMI after the adjustment for age, gender, education, and physical activity.
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1. Introduction
The prevalence of diabetes mellitus is high among Qatari adults reaching 16.7% [1]. The progression
of type 2 diabetes is accompanied with several complications such as neuropathy, retinopathy,
cardiovascular disease, infections (e.g., monilial skin infections), and cognitive impairment [2].
The increase in the Type 2 diabetes prevalence is associated with a change in sedentary life style
and obesity [3]. Different researches demonstrated that obesity, particularly abdominal obesity (AO),
which represents both subcutaneous and visceral fat accumulation, is associated with an increased
risk of cardiovascular and metabolic diseases in both adults and children [4]. It is well-known that
obesity is linked with insulin resistance, which plays an important role in the pathophysiology of type
2 diabetes and other metabolic disorders [5,6]. Body mass index (BMI) is a widely accepted and easily
applicable measure for obesity; it, however, cannot distinguish between fat and fat-free mass. Therefore,
an elevated BMI might not necessarily reflect an increased adiposity [7]. To overcome this weakness,
waist circumference (WC) has been used as indicators of abdominal obesity and is closely related to
noncommunicable diseases [8,9]. It has been shown that an excess of WC is associated with an increase
in the prevalence of cardiovascular diseases (CVD) and the risk of premature death even when BMI is
within a normal range [10]. It was also reported that the association between insulin resistance and
WC is better than that with BMI [11,12]. In 2012, Krakauer and Krakauer developed a new tool called a
body shape index (ABSI) that accompanies waist circumference, height, and weight [13]. According to
the authors, ABSI emphasizes the elevated risk of diseases related to central and general adiposity.
Therefore, ABSI is capable of depicting a crucial risk factor for premature mortality [13]. ABSI showed
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a predictive power to the risk of CVD and cancer [14]. ABSI can estimate both visceral abdominal
and general overall adiposities and can predict premature mortality better than WC and BMI [15].
ABSI has been validated to predict the risk of diabetes in several countries. However, the findings
are mixed. Some studies suggest that ABSI is a better predictor for diabetes [16,17]. However, other
studies showed ABSI is not a better predictor of diabetes than BMI [18].
The aim of this study is to assess the predictive level of ABSI for diabetes compared to BMI in
the Qatari population. We also aimed to assess the interaction between ABSI and BMI in relation
to diabetes.
2. Methodology
2.1. Study Design
The study is a population-based cross-sectional survey carried out between 2012–2014 for
60,000 men and women Qatari nationals and long-term residents (individuals living in the country
for ≥15 years) (Qatar Biobank study); the detailed methods of data collection and sampling has
been published elsewhere [19]. Exclusion criteria were a history of terminating diseases such as
muscle wasting, athletes, age <20 or >79, and pregnant women. A random sample of 2802 adults
aged 20–79 years was obtained from the Qatar Biobank survey data. Participants with incomplete
measurements were excluded (n = 266). The final number of participants included in this analysis
was 2536 (1275 males and 1261 females). Qatar Biobank recruitment and data collection protocols
were approved by the Hamad Medical Corporation Ethics Committee. The Institutional Review Board
approval for this study was obtained from Qatar Biobank.
2.2. Outcome Variable Diabetes
Diabetes was defined as having fasting glucose ≥7 mmol/dL, random glucose ≥11.1 mmol/dL,
HbA1c >6.5%, or self-reported doctor diagnosed diabetes [20]. Anthropometric measurements
including weight, height, and waist circumference were measured by competent registered nurses
in Qatar Biobank clinics. The participants were asked to wear light clothing and to be barefoot.
The weight was measured by kg and recorded to the closest 0.1 kg. The standing and sitting height
were measured and recorded to the closest 0.1 cm with the subject’s head in the Frankfurt plane.
The waist circumference (WC) was measured at the midpoint between the last rib and the top of
the iliac crest with stretch-resistant tape; the participants stood with their feet close together, arms
positioned on the side. The weight and height measures were used to calculate body mass index
(BMI, kg/m2). The BMI status (normal, overweight, and obese) of the participants were assigned based
on WHO BMI cutoff points [21]. DEXA-Full Body iDXA (GE) scan-scanners were used in measuring
the body distribution of visceral and trunk fat. It works by passing a low dose of x-ray radiation that
goes on the whole body of participants who were directed not to wear anything that might interfere
with the x-ray of the device like metal belts or jewelry. They were asked to wear a gown and to lie
flat on the screening for about 5 to 10 min, and for clear not blurry Full Body iDXA (GE) scan images,
participants were asked to hold still without moving and to hold their breath for a few seconds.
A body shape index (ABSI) was calculated using the Krakauer and Krakauer equation:
WC/(BMI2/3height1/2) [13]. The ABSI score was converted to a z-score using the following equation:
ABSI minus ABSImean divided by ABSISD. BMI was also converted to z-score. The z score was used to
measure the association of ABSI compared with BMI and the risk of diabetes. The z-score was used as
it makes the comparison meaningful because the unit change in the regression analysis is different for
ABSI and BMI.
2.3. Covariates
The education level, age, and physical activity of the participants were obtained through a main
questionnaire. Education was divided into three levels: Low education (up to secondary school),
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medium education (technical or professional school), and high education (university and above).
Leisure time physical activity levels (expressed as metabolic equivalents (MET) (hours/week) were
calculated based on the frequency and duration of different types of physical activity.
2.4. Statistical Analysis
The association between ABSI z-scores and diabetes was assessed using a logistic regression.
Four models were used: model 1 adjusted for age and gender; model 2 further adjusted for education;
model 3 further adjusted for physical activity; model 4 further adjusted for BMI. The association
between BMI (z-score) and diabetes was also assessed using the same approach. Subgroup analyses
were conducted and visually presented using a user-written syntax ipdover in Stata. All the analyses
were conducted in Stata 15.1. A p value < 0.05 was considered as statistically significant.
3. Results
Table 1 shows the sample characteristics by gender. The mean age was 38.3 in males and 40.1
in females. More than 60% of the participants had a high education level. The prevalence of obesity
was 39% (32.6% in men and 45.4% in women). Females had higher mean BMI and total fat mean than
males. Males had higher waist circumference and visceral fat (p < 0.001).
Table 1. Sample characteristics by gender.
Total Male Female p-Value
n = 2536 n = 1275 n = 1261
Age (years) 39.4 (11.1) 38.8 (10.6) 40.1 (11.6) 0.004
Education <0.001
Low 251 (9.9%) 94 (7.4%) 157 (12.5%)
Medium 707 (27.9%) 388 (30.5%) 319 (25.3%)
High 1576 (62.2%) 791 (62.1%) 785 (62.3%)
BMI (kg/m2) 29.0 (5.6) 28.4 (5.0) 29.6 (6.1) <0.001
BMI categories <0.001
Normal 603 (23.8%) 316 (24.8%) 287 (22.8%)
Overweight 944 (37.2%) 543 (42.6%) 401 (31.8%)
Obese 989 (39.0%) 416 (32.6%) 573 (45.4%)
Waist circumference (cm) 89.2 (13.5) 93.5 (12.4) 84.8 (13.2) <0.001
ABSI z score 0.0 (1.0) 0.7 (0.7) −0.7 (0.7) <0.001
Total mass (kg) 79.3 (16.3) 84.3 (15.2) 73.5 (15.7) <0.001
Total fat (kg) 30.9 (10.7) 28.6 (10.3) 33.4 (10.6) <0.001
Trunk fat (kg) 16.2 (6.4) 16.2 (6.6) 16.2 (6.2) 0.90
Visceral fat (kg) 1.0 (0.7) 1.3 (0.8) 0.8 (0.5) <0.001
Leisure time physical activity (MET hours/week) 18.2 (38.6) 22.4 (45.3) 13.9 (29.8) <0.001
Diabetes (%) 413 (16.3%) 191 (15.0%) 222 (17.6%) 0.073
The data are presented as mean (SD) for continuous measures and n (%) for categorical measures.
Table 2 shows the association between ABSI and BMI with diabetes using different logistic
regression models with progressive adjustments. After adjusting for age and gender, both ABSI
and BMI were positively associated with diabetes with an OR (95% CI) of 1.84 (1.54–2.21) and 1.38
(1.22–1.56) respectively. With a further adjustment for education, the OR for the risk of diabetes
with ABSI z-scores was 1.87 (95% CI: 1.55–2.24), whereas the OR for the association between the risk
of diabetes and BMI z-scores was 1.34 (95% CI: 1.55–1.19–1.52). After being mutually adjusted for
ABSI and BMI, the ORs for diabetes increased for both ABSI 1.94 (95% CI: 1.61–2.34) and BMI 1.40
(95% CI: 1.24–1.60). The association between ABSI, BMI and HbA1c was assessed using a multivariable
regression model where both indices were independently associated with HbA1c (refer to Figure S1 in
the Supplementary Materials).
Nutrients 2019, 11, 1018 4 of 6
Table 2. The association between A Body Shape Index (ABSI) and BMI with diabetes among
Qatari adults.
ABSI z-Score BMI z-Score
OR (95% CI) p OR (95% CI) p
Model 1 1.84 (1.54–2.21) <0.001 1.38 (1.22–1.56) <0.001
Model 2 1.87 (1.55–2.24) <0.001 1.34 (1.19–1.52) <0.001
Model 3 1.85 (1.54–2.23) <0.001 1.34 (1.18–1.51) <0.001
Model 4 1.94 (1.61–2.34) <0.001 1.40 (1.24–1.60) <0.001
Model 1 adjusted for age and gender; Model 2 further adjusted for education; Model 3 further adjusted for physical
activity; Model 4 further adjusted for the BMI z-score or ABSI z-score.
Figure 1 represents subgroup analyses of the association between ABSI and diabetes. There was
a significant interaction between gender and ABSI in relation to diabetes. The association between
ABSI and diabetes was stronger in women than in men. ABSI and diabetes were associated in all
subgroups of age ≥30. The highest association were observed in the second age (30–39 years) subgroup
(p < 0.001). Participants with a normal weight did not show a significant association between ABSI
and diabetes while overweight and obese did (p < 0.001); however, obese participants showed the
highest association between ABSI and diabetes (p < 0.001). As BMI became higher, the OR gradient for
diabetes associated with ABSI also became higher. The OR for diabetes associated with ABSI were 1.24,
1.79, and 2.20 among normal, overweight, and obese participants.
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4. Discus ion
This cross-sectional study assessed the predictive power f I d BMI on predicting the risk of
diabetes in the Qatari population. It was found in the current study that ABSI is associated with a risk
of diabetes to a greater extent as compared to BMI. Han et al. (2017) compared the predictive level of a
body shape index (ABSI) to other anthropometric parameters including body mass index (BMI), waist
to height ratio (WHtR), and waist circumference (WC) for the risk of developing type 2 diabetes mellitus
(T2DM) in chinses adults [22]. After adjusting for different cofounding variables, ABSI differentiated
between the cases and non-cases of diabetes; however, there was no difference in the predictive ability
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for T2DM when using ABSI or other anthropometric parameters [22]. Fujita and colleagues (2015)
conducted a prospective cohort study aimed at addressing whether ABSI could be used as a predictor
for the risk of developing type 2 diabetes mellitus and other chronic disease [23]. Researchers used
annual health examination data (2008 to 2012) from Chiba City Hall in Japan. Their study included
37581 nondiabetic subjects followed up for 4 years. An increased BMI, WC, and ABSI elevated the
risk of T2DM. Furthermore, the areas under the curve associated with ABSI regression models were
smaller than that for BMI or WC models, which indicates that ABSI may not a stronger predictor for
diabetes among Japanese population [23]. Similar findings were reported from an analysis of data
from an 11-year follow-up study [24]. The authors reported that ABSI was an inferior discriminator of
incident T2DM as compared to BMI and other anthropometric measures.
Interestingly, we found that the joint effect of BMI and ABSI is a better predicator for the risk of
diabetes than the ABSI and BMI alone. This finding is in line with a recent retrospective study about
the association between Body Shape Index (ABSI) with cardio-metabolic risk factors [16]. The study
was conducted on 6081 Caucasian adults. Generalized linear models (GLM) were used to assess both
sex and age and the adjusted association of the ABSI with binary and continuous cardio-metabolic
risk factors. The results showed that the joint contribution of BMI and ABSI produced significantly
improved associations for having a high fasting glucose, high triglycerides, and a low HDL but not
high blood pressure [16].
5. Conclusions
ABSI and BMI are significantly associated with diabetes in the Qatari population. ABSI is a
better predictor for the risk of diabetes than BMI after the adjustment for age, gender, education,
and physical activity.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6643/11/5/1018/s1,
Figure S1: Association between ABSI, BMI and HbA1c; Model adjusted for age and gender. ABSI and BMI were
mutually adjusted. Table S1: Sample characteristics by diabetes.
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